MERFISH 2.0

Vizgen is a privately held spatial biology and multiomics company that commercializes advanced tools for spatially resolved, single-cell transcriptomics and proteomics. The company's foundational technology, Multiplexed Error-Robust Fluorescence in situ Hybridization (MERFISH), was developed in the lab of co-founder Xiaowei Zhuang at Harvard University. Vizgen's product portfolio includes the MERSCOPE and MERSCOPE Ultra imaging platforms, the next-generation MERFISH 2.0 chemistry, InSituPlex protein assays (acquired via its merger with Ultivue), and the AI-driven STARVUE spatial image analysis software. These tools enable researchers in oncology, neuroscience, and immunology to map RNA and protein expression with subcellular resolution in intact tissue. Vizgen operates as a commercial-stage platform provider, serving academic institutions and pharmaceutical companies globally.